文献速递腹部CT

利用CT特征鉴别自身免疫性胰腺炎与胰腺导管腺癌:系统综述与Meta分析

Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2023-07-19

该系统综述与Meta分析纳入15项研究(562例自身免疫性胰腺炎和869例胰腺导管腺癌患者),将145个描述词归为16种CT特征,计算各特征的合并诊断比值比(DOR)。弥漫性胰腺增大(DOR 48)、延迟均匀强化(DOR 46)和包膜样边缘(DOR 34)最提示自身免疫性胰腺炎,而局限性胰腺肿块(DOR 23)最提示胰腺导管腺癌;但除延迟均匀强化外,提示自身免疫性胰腺炎的特征敏感度较低(12-63%)、特异度较高(93-99%)。

要点

  • 弥漫性胰腺增大(DOR 48)、延迟均匀强化(DOR 46)、包膜样边缘(DOR 34)最提示自身免疫性胰腺炎。
  • 局限性胰腺肿块(DOR 23)是提示胰腺导管腺癌的CT特征中合并DOR最高者。
  • 除延迟均匀强化(敏感度83%、特异度85%)外,提示自身免疫性胰腺炎的特征敏感度较低(12-63%)但特异度较高(93-99%)。

核心结论

  • 11种CT特征有助于鉴别自身免疫性胰腺炎与胰腺导管腺癌;弥漫性胰腺增大、延迟均匀强化和包膜样边缘提示自身免疫性胰腺炎的DOR最高,而局限性胰腺肿块提示胰腺导管腺癌。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE和Cochrane图书馆,纳入15项研究(562例自身免疫性胰腺炎和869例胰腺导管腺癌患者),将145个描述词归为16种CT特征,采用双变量随机效应模型计算各特征的合并DOR。

关键影像表现/征象

  • 提示自身免疫性胰腺炎的CT特征:弥漫性胰腺增大(DOR 48)、延迟均匀强化(DOR 46)、包膜样边缘(DOR 34)、多发胰腺肿块(DOR 16)、肾脏受累(DOR 15)、腹膜后纤维化(DOR 13)、胆管受累(DOR 8)。
  • 提示胰腺导管腺癌的CT特征:局限性胰腺肿块(DOR 23)、胰管截断(DOR 16)、上游主胰管扩张(DOR 8)、上游胰腺实质萎缩(DOR 7)。

诊断标准与关键数值

  • 延迟均匀强化鉴别自身免疫性胰腺炎与胰腺导管腺癌的合并敏感度为83%、特异度为85%。
  • 除延迟均匀强化外,其余6种提示自身免疫性胰腺炎的特征敏感度为12-63%、特异度为93-99%。

临床应用与阅片要点

  • 阅片时需关注弥漫性胰腺增大、延迟均匀强化和包膜样边缘等提示自身免疫性胰腺炎的特征。
  • 局限性胰腺肿块、胰管截断、上游主胰管扩张和上游胰腺实质萎缩提示胰腺导管腺癌。
  • 作者指出这些特征有助于鉴别自身免疫性胰腺炎与胰腺导管腺癌,可能避免对表现为局限性或弥漫性胰腺增大的患者误诊。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine informational CT findings for distinguishing autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC) and to review their diagnostic accuracy.

METHODS: A systematic and detailed literature review was performed through PubMed, EMBASE, and the Cochrane library. Similar descriptors to embody the identical image finding were labeled as a single CT characteristic. We calculated the pooled diagnostic odds ratios (DORs) of each CT characteristic using a bivariate random-effects model.

RESULTS: A total of 145 various descriptors from 15 studies (including 562 AIP and 869 PDAC patients) were categorized into 16 CT characteristics. According to the pooled DOR, 16 CT characteristics were classified into three groups (suggesting AIP, suggesting PDAC, and not informational). Seven characteristics suggesting AIP were diffuse pancreatic enlargement (DOR, 48), delayed homogeneous enhancement (DOR, 46), capsule-like rim (DOR, 34), multiple pancreatic masses (DOR, 16), renal involvement (DOR, 15), retroperitoneal fibrosis (DOR, 13), and bile duct involvement (DOR, 8). Delayed homogeneous enhancement showed a pooled sensitivity of 83% and specificity of 85%. The other six characteristics showed relatively low sensitivity (12-63%) but high specificity (93-99%). Four characteristics suggesting PDAC were discrete pancreatic mass (DOR, 23), pancreatic duct cutoff (DOR, 16), upstream main pancreatic duct dilatation (DOR, 8), and upstream parenchymal atrophy (DOR, 7).

CONCLUSION: Eleven CT characteristics were informational to distinguish AIP from PDAC. Diffuse pancreatic enlargement, delayed homogeneous enhancement, and capsule-like rim suggested AIP with the highest DORs, whereas discrete pancreatic mass suggested PDAC. However, pooled sensitivities of informational CT characteristics were moderate.

CLINICAL RELEVANCE STATEMENT: This meta-analysis underscores eleven distinctive CT characteristics that aid in differentiating autoimmune pancreatitis from pancreatic adenocarcinoma, potentially preventing misdiagnoses in patients presenting with focal/diffuse pancreatic enlargement.

KEY POINTS: • Diffuse pancreatic enlargement (pooled diagnostic odds ratio [DOR], 48), delayed homogeneous enhancement (46), and capsule-like rim (34) were CT characteristics suggesting autoimmune pancreatitis. • The CT characteristics suggesting autoimmune pancreatitis, except delayed homogeneous enhancement, had a general tendency to show relatively low sensitivity (12-63%) but high specificity (93-99%). • Discrete pancreatic mass (pooled diagnostic odds ratio, 23) was the CT characteristic suggesting pancreatic ductal adenocarcinoma with the highest pooled DORs.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yoon SB, Jeon TY, Moon SH, et al. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Eur Radiol. 2023. PMID: 37466708. doi:10.1007/s00330-023-09959-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。